Supporting evidence
Hybrid closed-loop system × HbA1c
- Authoritative support
- 4
- Available studies
- 4
- Unavailable support
- 0
Available supporting studies
Study 1 · Included
AHCL therapy improves glucose levels but increases diabetes distress in youth
Rct
- Comparison
- Participants used the AHCL algorithm in the Medtronic MiniMed insulin pump for 6 months. · Participants in the control arm continued their usual treatment.
- Duration / follow-up
- 26 weeks
Relevant effect
Mean difference
1.1
Study 2 · Included
AID improves glycaemia but worsens sleep in young T1D patients
Rct
- Comparison
- Participants received automated insulin delivery for 13 weeks. · Participants received usual care for 13 weeks.
- Duration / follow-up
- 1300 weeks
Relevant effect
Mean difference
34 · 0.001
Study 3 · Included
Hybrid telemedicine improves glycemic control in type 1 diabetes
Rct
- Comparison
- Participants received a hybrid follow up program incorporating telemedicine consultations alongside face to face visits. · Participants received conventional face to face follow up care following standard clinical practice.
- Duration / follow-up
- 52 weeks
Relevant effect
Mean difference
0.2 · 0.006
Study 4 · Included
Tubeless AID system improves glycemic outcomes in type 1 diabetes
Rct
- Comparison
- Participants used the Omnipod 5 AID System for 13 weeks. · Participants continued using their usual insulin pump with a Dexcom G6 CGM.
- Duration / follow-up
- 13 weeks
Relevant effect
Mean difference
1.24 · 0.0001